Trials / Withdrawn
WithdrawnNCT04511936
Microcurrent Stimulation for Dry Age-related Macular Degeneration
Microcurrent Stimulation Therapy for Dry Age-related Macular Degeneration (i-SIGHT): a Multicenter, Randomized, Double-masked, Clinical Device Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- i-Lumen Scientific, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry age-related macular degeneration.
Detailed description
Multi-center, double-masked, randomized trial of microcurrent stimulation for the treatment of patients affected with dry age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | i-Lumen AMD | Microcurrent stimulator |
| DEVICE | i-Lumen AMD Sham | Sham microcurrent stimulator |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2022-01-31
- Completion
- 2023-01-31
- First posted
- 2020-08-13
- Last updated
- 2021-04-08
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04511936. Inclusion in this directory is not an endorsement.